Del Mar, CA, United States of America

Keith Hoffman

This inventor holds 2 USPTO granted patents. Top assignee: Ancile Pharmaceuticals, Inc.. Active years: 2002-2003.


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keith Hoffman: Innovator in the Treatment of Restless Leg Syndrome

Introduction

Keith Hoffman is a notable inventor based in Del Mar, California. He has made significant contributions to the field of medicine, particularly in the treatment of Restless Leg Syndrome (RLS) and related disorders. With a total of 2 patents, Hoffman's work focuses on innovative methods to alleviate the symptoms associated with this condition.

Latest Patents

Hoffman's latest patents include a method for using Valeriana to treat Restless Leg Syndrome and its related disorders. This method involves identifying a host afflicted with RLS and administering a pharmaceutically effective amount of Valeriana. The patent details a novel approach to inhibiting symptoms of RLS, including periodic limb movements during sleep. The method may also involve the administration of specific compounds found in Valeriana extracts, such as Valerenal and Valerenic acid, to diminish undesired limb movements.

Career Highlights

Keith Hoffman is currently associated with Ancile Pharmaceuticals, Inc., where he continues to develop innovative treatments for various medical conditions. His work has garnered attention for its potential to improve the quality of life for individuals suffering from RLS.

Collaborations

Hoffman collaborates with Costas Loullis, contributing to the advancement of research and development in their field. Their partnership aims to enhance the effectiveness of treatments for patients.

Conclusion

Keith Hoffman is a dedicated inventor whose work in the treatment of Restless Leg Syndrome showcases his commitment to medical innovation. His patents reflect a deep understanding of the complexities of this condition and offer promising solutions for those affected.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…